Alcoholic beverages which are consumed widely in most parts of the world have long been identified as a major risk factor for all liver diseases, particularly alcohol-induced liver disease (ALD). Recent compositional analyses suggest that Chinese Baijiu (CB), a clear alcoholic liquid distilled from fermented grains, contains large amounts of small molecule bioactive compounds in addition to a significant amount of ethanol. Here, in an experimental mouse model, we show that CB caused lower degrees of liver injury than pure ethanol by protecting against the decrease of the relative abundance of Akkermansia and increased relative abundance of Prevotella in the gut thereby preventing the destruction of the intestinal barrier. Furthermore, we demonstrated that ethanol-induced alteration of the gut microbiota profoundly affected the host metabolome. Compared with ethanol feeding, CB feeding resulted in higher concentrations of functional saturated LCFAs and SCFAs. Our results provide supporting evidence that ALD was profoundly influenced by host-gut microbiota metabolic interactions and that small molecule organic compounds in CB could attenuate ALD.
Introduction
As a public health problem, alcoholic liver disease (ALD) is a major factor in the burden of disease and also one of the leading causes of liver-related deaths worldwide 1 ; 2 . A recent epidemiological study has estimated that approximately 50% of all cirrhosis-associated deaths are related to alcohol 3 . Hence, the health and social issues related to alcohol use and misuse need attention urgently. However, a growing number of researchers have suggested that moderate drinking benefits healthy adults in many ways. Drinking in moderation has been reported to reduce the risk of cardiovascular diseases 4 , diabetes 5 , and may have protective effects against ischemic stroke 6 and osteoporosis 7 .
Although the underlying mechanisms are incompletely understood, the importance of the intestinal microbiota in the pathogenesis of ALD is increasingly recognized 8, 9, 10 . Alcohol-induced gut microbiota dysbiosis destroys the intestinal barrier function and increases the intestinal permeability, which results in increased translocation of bacterial components, bacteria, and metabolites from the gut to the liver through the portal vein and the systemic circulation. Lipopolysaccharide (LPS), a Gram-negative bacteria cell wall component, engages in a complex signaling cascade through different receptors in the innate immune system. By activating the NF-κB pathway, LPS induces transcription of various pro-inflammatory cytokines and chemokines which are considered important mediators of liver-gut communication 11, 12 .
In addition to inducing dysbiosis, alcohol alters the metabolic composition of the gastrointestinal contents 13 . The intestinal microbiome performs a diverse range of metabolic functions including production of numerous metabolites that serve as the nutritional sources for microbes and important messengers between the microbiota and the host 14 . The alteration of the metabolome caused by dysbiosis can find evidence in many metabolic diseases and therefore, this microbiome-metabolome homeostasis is important for the host health 15, 16 . However, supporting scientific data about the microbiome-metabolome interactions remain sparse in mouse models of ALD.
Distilled liquor is a group of important beverage products both culturally and economically. It is a complex mixture of water, ethanol, and thousands of small molecule chemical compounds 17, 18 . Recent studies have shown that many distilled liquors contain bioactive compounds and have certain antioxidant activity. For example, brandy and whiskey were found to have antioxidant activity and this activity was associated with their total phenolic content 19 . Likewise, Chinese Baijiu (CB), a traditional Chinese fermented beverage, was also found to have many compounds with potential bioactivity 20 . CB is produced from multi-strain and solid-state fermentation techniques that produce large numbers of various fermentation metabolites, such as esters, alcohols, aldoketones, acids and many other compounds that were bioactive including short chain fatty acids, phenols and heterocyclic compounds 17 . Therefore, we hypothesized that, in chronic alcoholism, grain-derived fermentation metabolites in CB have a hepatoprotective effect and CB ingestion may cause lower levels of liver injury compared with the same dosage of ethanol (EtOH).
In this study, to verify our hypothesis, we developed a chronic EtOH gavage mouse model and compared the effects of CB and EtOH intervention on the liver. In addition, to elucidate how CB may affect the gut microbiota and their metabolome, and discriminate such changes from EtOH-induced alterations, we compared the effects of CB and EtOH on the intestinal microbiota and metabolic parameters, including short chain fatty acids (SCFAs). As far as we know, this is the first study that reveals the effect of distilled liquor on intestinal microflora and their metabolism.
Our results may improve our understanding of the host-gut microbiota metabolic interactions during the progression of ALD.
Results

Chinese Baijiu and its compositions
CB used in this study is a distilled liquor produced at Guizhou, China and was purchased from local market. The chemical compositions of CB were identified using a mass spectrometry-based metabolomics approach and provided in Table S1 .
CB and EtOH intervention lowered the food consumption and body weight and increased the liver weight/body weight (LIV/BW) ratio.
To explore the effect of EtOH consumption on phenotype, we performed a 12-week intragastric administration experiment. Figure 1A is a diagrammatic representation of the alcohol dosing experiment. During the feeding trial period, all mice were eating and drinking normally except for one EtOH treated mouse which died at week 11. The food consumption of both CB-and EtOH-fed mice, however, were significantly lower relative to control mice ( Fig. 1B ) and these differences in food consumption were directly reflected in the body weights of the mice (Fig. 1C ). The body weight of experimental mice were significantly lower than control mice except for the 8-week CB-fed mice where no significant change was observed ( Fig. 1D ) based on the fact that the initial weight of mice in each group had no significant differences (Table S2) .
As expected, the LIV/BW ratio of experimental mice were higher than the control mice and the LIV/BW ratio of EtOH-fed mice were higher than those treated with CB ( Fig. 1D ), although this difference was observed to be significant only at week 4. The observed increase in the LIV/BW ratio of ethanol-fed mice (either CB or EtOH) led us to hypothesize that the changes were caused by liver injury and fatty liver. The attenuated effect of CB relative to EtOH on the LIV/BW ratio was supporting evidence for CB being less hepatotoxic.
CB feeding resulted in a lower level of hepatic injury and steatosis than EtOH feeding.
To determine whether different phenotypes caused by CB and EtOH intervention directly translated into differences in ALD, the biochemical and pathological changes induced by CB and EtOH were further characterized. First, steatosis and lipid accumulation in liver tissue were observed by H&E ( Figure 2A ) and oil red O staining ( Fig. 2B ). The EtOH-fed mice exhibited both micro-and macrovesicular steatosis at 4 weeks following alcohol administration while it was not observed in CB-fed mice until week 12 ( Fig. 2A ). Hepatic fat accumulation was also markedly lower in CB-fed mice compared with EtOH-fed mice (Fig. 2B ). Biochemical analyses including plasma alanine aminotransferase (ALT) and hepatic triglyceride (TG) levels were measured and although both CB and EtOH feeding lead to significant increases in plasma ALT ( Fig. 2C ) and accumulation of hepatic TGs (Fig. 2D ), CB gavage partially prevented liver injury, as assessed by lower plasma ALT levels, and less TGs relative to EtOH treated mice. In addition, CB-fed mice had significantly lower levels of thiobarbituric acid-reactive substances (TBARS) compared EtOH treated mice which indicated that CB treatment caused lower levels of hepatic oxidative stress ( Fig.   2E ). These results led us to hypothesize that the bioactive compounds in CB exerted a hepatoprotective effect because even though both CB and EtOH-fed mice were exposed to an equivalent amount of ethanol, there was less EtOH induced toxicity found in the CB group.
CB and EtOH feeding resulted in different intestinal community structures.
Recent advances in ALD research have elucidated the importance of gut microbiota in the development and progression of ALD 11, 21 . Our findings indicated that CB feeding caused lower levels of liver injury than EtOH feeding. To investigate whether the observed differences in liver injury between mice fed CB and those fed EtOH in our model were associated with the differences in the intestinal microbiota, we analyzed the caecal microbiota by sequencing the V3-V4 amplicons of 16S rRNA genes. We hypothesized that EtOH-fed mice would experience a distinct composition from both control and CB mice.
After trimming, assembly and quality filtering, the resulting sequences were delineated into 657 operational taxonomic units (OTUs) at the similarity cutoff of 97%. Ninety nine percent of OTUs were detected by at least two DNA reads, demonstrating thorough sampling of the gut microbiota. Rarefaction analysis showed that all the caecal microbial diversity in each sample was captured with the current sequencing depth ( Fig. S1 ). OTU-based unweighted unifrac PCoA analysis revealed that the gut microbiota structure of the treated groups showed a time-dependent variation ( Fig. 3A ) and that the experimental groups significantly differed from the control ( Fig. 3B ). Taxonomy-based analysis at the phylum level revealed that the phyla Firmicutes, Verrucomicrobia, Proteobacteria and Bacteroidetes dominated the caecal microbial communities ( Fig. S2 ). Experimental mice had notable increases in the phylum Proteobacteria and decreases in phylum Actinobacteria. Although the relative abundances of the phyla Firmicutes and Bacteroidetes showed no significant changes, their ratio, considered to be of significant relevance to the gut microbiota composition 22 , was significantly lower in the treated mice than in the control mice especially for the EtOH-fed mice (Fig. S3 ). In addition, we also observed that the percentages of Gram-negative (G-) bacteria increased in the experimental groups ( Fig.   S4 ). Despite EtOH's key role in affecting gut flora, clear differences in the bacterial composition between mice fed CB and those fed EtOH were observed and these differences tended to be expanded (Figs. S5, S6). Our results were congruent with multiple lines of evidence that EtOH intake induces gut dysbiosis 23, 24 and, moreover, CB and EtOH feeding lead to different caecal community structures, thus proving our initial hypothesis that the EtOH-fed mice would have a distinct microbiota composition from that of CB-fed mice.
In order to determine the key OTUs responding to the CB and EtOH, redundancy analysis (RDA) was performed using different treatments at different times as environmental variables ( Fig. 3C ). Similar to the results discussed above, a difference in composition of caecal microbiota between CB-and EtOH-fed mice was observed.
Eight-and twelve-week treatments of CB groups are located at the left of the RDA1 together with the control groups, while the 4 week CB treatment group and EtOH groups are located at right of the RDA1. This result further confirmed the differences in the caecal microbial communities between CB and EtOH treatment groups and revealed that the community structure tended to be more similar between CB and control group than between EtOH and control group. In addition, a total of 28 key OTUs were identified, among which 19 OTUs were increased by EtOH. These increased OTUs belong to Oscillospira (n=4), Helicobacter (n=2), unclassified S24-7 (n=4), and one OTU to each of the following genera: Ruminococcus, AF12, Alistipes, Clostridium Bacteroides, Prevotella, Anaeroplasma, unclassified OTUs of the families Bacteroidales and Christensenellaceae. The rest of the 9 OTUs that were decreased by EtOH treatment belonged to the genera Akkermansia (n=2), unclassified S24-7 (n=3), Pseudoflavonifractor (n=2), Dorea (n=1) and Ruminococcus (n=1) (Tables S3, S4 ).
Intestinal barrier functions of CB-treated mice were more complete relative to EtOH-treated mice.
By comparing the key OTUs derived from RDA between CB and EtOH treated groups ( Fig. S7 ), we found that CB-treated mice had higher levels of OTUs affiliated with the genus Akkermansia (OTU1) than EtOH-treated mice from week 8 onwards ( Fig. 4A ). An increasing amount of research has disclosed that the abundance of Akkermansia is positively correlated with the integrity of the intestinal barrier 25 .
Epithelial tight junctions are critically important to maintain barrier integrity and influence intestinal epithelial leakage 26 . Hence, we hypothesized that a diminished abundance of Akkermansia in EtOH-fed mice would result in a decrease in the tight junction protein expression in the ileum tissue of these mice. Although both CB and EtOH treatment reduced the expression of occludin, CB-fed mice had significantly higher levels of occludin than those of EtOH-fed mice (Figs. 4B, C). Claudin-2 forms pores to increase barrier leakiness 27 . Levels of claudin-2 increased in EtOH-fed mice relative to CB-fed mice (Figs. 4D, E). Destruction of intestinal barrier function would lead to leakage of microorganisms and their products and induce endotoxemia. Accordingly, we measured the serum LPS level. As expected, the CB-fed mice had significantly lower levels of serum LPS than EtOH-fed mice (Fig. 4F ). These results suggest that CB feeding may attenuate the ethanol-induced decrease of Akkermansia populations which, in turn, if at higher abundance, may ameliorate the destruction of intestinal barrier function.
CB and EtOH treatment resulted in two distinct caecal metabolomes
Although the associations between gut microbiota and pathogenesis of ALD has been well established 11, 28 , the effects of the altered gut microbiota on their metabolic profiles are poorly understood. Therefore, in addition to understanding how EtOH and CB altered gut community structure, we investigated how gut community structure impacts function. The metabolic profiles of caecal contents were therefore analyzed using untargeted metabolomics.
The time-dependent metabolic "footprints" of the caecal metabolome showed that control groups were clearly separated from the experimental groups using first principal component (PC1), while the second principal component (PC2) further differentiated the EtOH and CB groups revealing that the distance between them tended to expand in a time-dependent manner (Figs. 5A, B). These results suggested that the altered gut microbiota caused functional changes. To further characterize the metabolic perturbation in response to CB and EtOH feeding, metabolites that were altered were subjected to a two-tailed unpaired t-test and statistical significance was decided on the basis of a p value of less than 0.05 and a VIP value more than 1. A total of 44 differential metabolites were identified in this way. Among these metabolites, 15
were related to amino acid metabolism, 14 were lipid-related metabolites that were primarily saturated long-chain fatty acid (LCFAs). In addition, there were 8 carbohydrate-related metabolites, 2 that were relevant to gut microbial metabolism, 1 for bile acid metabolism and 4 metabolites were categorized as miscellaneous ( Fig.   S8 ). The alteration of metabolites with various functions and our previous data regarding changes in gut microbiota composition suggest that these important impacts were caused by administration of EtOH. Of these differential metabolites, we observed that CB-fed mice had lower concentrations of carbohydrates than that of the EtOH-fed group. Because gut bacterial species across many taxa share the genes for fermenting carbohydrates into short-chain fatty acids (SCFAs) 29 , we hypothesized that CB-fed mice had a higher content of SCFAs in their gut lumen relative to EtOH-fed mice. Hence, we quantified SCFA concentrations in the mouse colonic contents ( Fig.   5C ). Although both CB and EtOH feeding led to increased acetate and decreased butyrate levels 13 , consistent with our hypothesis, CB-fed mice had higher colonic concentrations of most SCFAs (ie. acetic acid, butyric acid, isobutyric acid and valeric acid) than was found for EtOH-fed mice, especially for acetic and butyric acids ( Fig.   5D , E, S9). Similar to the findings for the gut microbiome, these results indicated that although alcohol feeding notably altered the gut metabolome, clear differences in the gut metabolome were observed between mice fed CB and mice fed EtOH.
Correlations between key OTUs, differential metabolites and SCFAs
Understanding the interactions of microbiome and their metabolome holds promise for functional characterization of gut microbiota and for understanding human health and disease 30 . As such, we established the association between altered gut microbiota and their metabolism using correlation analyses and visualized interactions of microbiome and their metabolome by examining the caecal microbial composition and its metabolite profile ( Fig. 6) .
At the OTU level, we observed a clustering of metabolites related to carbohydrate metabolism (rhamnose, galactose, glucose and sucrose), amino acid metabolism (L-cysteine, L-glutamine, quinic acid, 5-hydroxylysine) and lipid metabolism (arachidic acid, behenic acid, cholesterol and tetracosanoic acid) with a number of microbes, including a positive correlation between these metabolites and OTUs belonging to the genera Pseudoflavonifractor, Dora, Ruminococcus, Akkermansia and unclassified S24-7, and also a negative correlation was observed between these metabolites and OTUs belonging to the genera Oscillospira, Anaeropiasma, and Helicobacter. Interestingly, some metabolites related to lipid metabolism (dodecanoic acid, glycerol 1-octadecanoate and pelargonic acid) had inverse correlations with members of these genera indicating a diverse genetic potential of these OTUs. In addition, we also observed correlations between members of these genera with SCFAs, specifically a positive correlation with members of genera Pseudoflavonifractor and unclassified S24-7 and a negative correlation with the genera, Oscillospira, Ruminococcus, Bacteroides, AF12, Alistipes, Prevotella and unclassified S24-7.
Low dosages of administered CB vs. EtOH were used to verify the hepatoprotective effect of compounds in CB.
The above results suggested that the different interventions (CB vs. EtOH) led to differences in gut flora and their functions. These differences directly translated into differences in ALD with CB gavage resulting in lower levels of liver injury than gavage with EtOH. In order to verify whether a lower dosage of CB or EtOH affects liver following the same rules, we treated mice with a lower, 1.5-fold standard treatment incorporating either CB or EtOH (Fig. 7A ). As expected, no obvious hepatic steatosis and lipid accumulation were observed in the CB-treated group during the entire experiment. However, light hepatic steatosis and lipid accumulation occurred in the EtOH-treated group at week 12 (Fig. 7B,C) . Likewise, there were no significant differences in the level of plasma ALT and hepatic triglycerides between the CB-treated group and the control group. As for the EtOH-treated group, significantly increased levels of plasma ALT and hepatic triglycerides were observed from weeks 8 and 12 onward, respectively (Fig. 7D,E) . These results further confirm our original hypothesis that chemical compounds in CB ameliorate ethanol-induced liver injury.
Discussion
Baijiu is a type of traditional Chinese fermented alcoholic beverage, and also one of the earliest distilled liquors with written records that dated back to the Ming Dynasty (1368-1644 A.D.). Today, Baijiu is not only part of a unique cultural heritage, but has become a major consumer product with important economic values. Recent studies with the compositional analysis of CB determined that it contained abundant amounts of small molecule bioactive compounds 20, 31 . In this study, we hypothesized that these flavor compounds protect against ethanol-induced liver injury. To verify this hypothesis, we set out to compare the effect of CB and ethanol on liver through Two potential mechanisms reported for the observed higher abundance of A. muciniphila involved the antioxidant and antimicrobial effect of some compounds in CB. CB is abundant with many phenolic and heterocyclic compounds 20, 35 which have been shown to possess remarkable antioxidant effects 36, 37 . A. muciniphila is an obligate anaerobe, lacking protection against free oxygen radicals 38 . Therefore, it is tempting to speculate that the oxygen radical scavenging capacity of these compounds can provide a survival advantage to A. muciniphila. Regarding the antimicrobial effect of these compounds, it has been suggested that phenolic compounds exert profound antimicrobial activity and are capable of stimulating the growth of Akkermansia in the transversal colon 39 . In addition, Akkermansia was found to be negatively associated with Prevotella 40 , whose relative abundance was significantly lower in the CB treatment group than in EtOH treatment group (Fig. S10 ). As such, the antimicrobial effect of CB could be associated with a reduction in the abundance of species capable of holding Akkermansia in check, thus favoring a rise in its proportion. Importantly, Prevotella has also been identified to be a LPS-producing genus with a pro-inflammatory function. In a mouse model of gut inflammation, animals colonized with P. copri had more severe disease than controls 41 . Whereas, Akkermansia was found to be a LPS-suppressing genus 42 . Significant lower relative abundance of the genera Prevotella and higher relative abundance of the genera Akkermansia in the CB treatment group could also explain why the liver and serum LPS level of the CB group were significantly lower than that seen in the EtOH group.
Another interesting finding from the current study was that there were significant differences observed in the caecal metabolome between CB-fed and EtOH-fed mice.
These results indicated that ALD, like many other metabolic disorders such as nonalcoholic fatty liver disease 43 , type 2 diabetes 44 and cardiovascular disease 45 , may be coordinately influenced by intestinal microbiome and metabolome.
Importantly, we observed a better metabolic activity of caecal microbiota of CB-fed mice that was manifested by elevated SCFA production, especially for acetate and butyrate. Similar to our findings, a previous study also observed that ethanol feeding increased the content of acetate in the gut lumen 13 . This can be explained by the enrichment of the functions related to ethanol metabolism of gut microbiota after ethanol feeding 46 . Acetic acid is the end product of ethanol metabolism. Higher concentrations of acetate in CB-fed mice suggested a higher detoxification for ethanol and/or acetaldehyde for the CB-fed mice 13 . As for butyrate, the other SCFA that was elevated in CB mice relative to EtOH mice, it plays multiple roles in intestinal and host health such as, enhancing the intestinal barrier function by activating AMP-activated protein kinase (AMPK) and regulating the assembly of tight junctions 47 . A recent study in experimental ALD found that butyrate supplementation protected against alcohol-mediated intestinal tight junction disruption and liver inflammation 48 . Butyrate is also an important energy source for intestinal epithelial cells and has been shown to be protective against colorectal cancer, partly by inhibiting histone deacetylases (HDACs) 49 which are vital regulators of fundamental cellular events, such as cell cycle progression, differentiation, and tumorigenesis 50 . In addition to being an anti-tumor agent, butyrate is also a potent anti-inflammatory agent. By stimulating the development of regulatory T cells, butyrate can induce the production of the anti-inflammatory interleukin-10 (IL-10) which has the ability to prevent inflammatory reactions against pathogenic microbes 51, 52 . In fact, along with the cells that produce mucin (goblet cells) and those that maintain tight junctions (enterocytes), the gut immune cells are also considered part of the intestinal barrier 11 .
Another impressive finding concerning the metabolic differences between the two experimental groups CB and EtOH, was that CB-fed mice had higher levels of saturated LCFA (ie. dodecanoic acid, heptadecanoic acid, stearic acid, arachidic acid, behenic acid, tetracosanoic acid) than EtOH-fed mice (Fig. S4) 53, 54 . However, in our mice model, we did not find any OTU belonging to this genus in the caecum even in the control mice. This discrepancy might be due to several factors, such as different animal models of ALD (eg, ad libitum vs. intragastric ethanol administration), different durations of alcohol feeding, variability in the specific dietary components (eg, diets containing different types of fat and/or fermentable fibers), and also different sequencing methods (16S amplicon versus metagenome). Otherwise, it is possible that saturated LCFAs protect against ethanol-induced liver injury by other mechanisms than simply by increasing intestinal levels of probiotic Lactobacillus.
Although the mechanism was not determined, we demonstrated that compounds in CB can prevent the loss of intestinal saturated LCFA and reduce ethanol-induced liver injury in mice. Our results support the concept that diets or agents designed to increase intestinal concentrations of saturated LCFA or their production by the intestinal microbiome might be developed to treat alcohol-induced liver disease 24 .
Materials and methods
Animal experiments
Specific pathogen-free (SPF) wild-type C57/B6 mice (male, age 7-8 weeks, weight 20-23 g) were obtained from Shanghai Laboratory Animal Co, Ltd. (SLAC, Shanghai, China). The mice were housed in a controlled environment at 22 ± 2 °C with 40%-60% humidity and a 12 h light-dark cycle. Mice had access to water and fodder ad libitum and their body weight and general health were closely monitored. After a one week acclimatization period, mice were randomly divided into three treatment groups: the Control group (vehicle only), CB group and EtOH group. As it was not practical to enforce each mouse to intake a defined dose of ethanol by ad libitum, all the animals were given EtOH or CB solutions by oral gavage. In order to be consistent with the experimental groups, normal control mice received the vehicle (water). To ensure the consistent gavage volume, CB and EtOH were diluted to the same EtOH concentration before use. The initial dosage of EtOH (3.2 g/kg per day) was increased in a stepwise manner 0.6 g/kg every 5 days until the 20th day (5.6 g/kg every) and then kept constant to the end of the experiment. This amount of EtOH was equivalent to approximately 3 standard drinks for a human. The confirmatory animal model consisted of three similar groups: the Control group, CB group and EtOH group with a lower dosage of the treatments. The initial dosage of EtOH (1.8 g/kg per day) was increased in a stepwise manner 0.3 g/kg every 5 days until the 15th day (2.7 g/kg every) and then kept constant until the end of the experiment. The amount equivalent to about 1.5 drinks in humans. The dosage was based on standard drink amounts set by NIH and previous work published by others 55 . Body weight gain and food intake were assessed once a week. Following 4, 8 weeks or 12 weeks of CB or EtOH feeding, mice were sacrificed by cervical dislocation after fasting overnight. Caecal contents were excised and stored at -80ºC immediately for further analysis. Blood was collected from the inferior vena cava, and citrated plasma was stored at -80°C for further analysis. Portions of liver and ileum tissues were fixed with 10% formalin for sectioning, while others were snap-frozen with liquid nitrogen and then stored at -80º C. All mice were harvested between 08:00 and 11:00 56 and received humane care in compliance with institutional guidelines.
Biochemical analyses
Serum alanine aminotransferase (ALT) activity was colorimetrically measured using the Infinity ALT kit (Thermo Scientific). Hepatic triglyceride levels were measured using the Triglyceride Liquid Reagents Kit (Pointe Scientific, Canton, MI) according to the manufacturer's instructions. Hepatic lipid peroxidation was quantified by measuring malondialdehyde using the thiobarbituric acid reactive substances (TBARS) assay (BioVision, Milpitas, CA, USA). Plasma LPS levels were measured by a commercial ELISA kit (CUSABIO, Wuhan, China).
Staining Procedures
Formalin-fixed tissue samples were embedded in paraffin and stained with hematoxylin and eosin (H&E) to assess the histological features of steatosis and inflammation. For hepatic lipid accumulation analysis, frozen sections of fresh liver tissues embedded in OCT compound (Sakura) were cut and stained with Oil Red O.
For immunofluorescence analysis of intestinal tight junction proteins, frozen intestinal sections were treated with anti-occludin and anti-claudin-2 antibodies (Invitrogen, Carlsbad, CA), followed by staining using a fluorescein isothiocyanate-conjugated secondary antibody (Servicebio, Wuhan, China). Laser-scanning confocal microscopy (Nikon D-Eclipse C1) was used for observation, and images were captured using a Nikon DS-U3 camera.
Real-Time quantitative polymerase chain reaction
Total RNA from ileum tissue was isolated using TRIzol reagent (Invitrogen, Carlsbad, 
Metabolomic analysis of caecal contents by GC-TOFMS
The metabolites extraction and derivatization procedures for the caecal contents were A sample of mixed standards was used as quality control and was injected every 10
injections.
Compound identification
The acquired data files from GC-TOFMS were processed by ChromaTOF software (v4.51.6.0, Leco, CA). After the pretreatment for baseline correction, denoising, smoothing, alignment, and deconvolution, raw data containing retention time, intensity, and the mass-to-charge ratio of each peak were obtained. Compounds were identified by comparing the mass fragments with NIST 05 standard mass spectral databases in NIST MS search 2.0 (NIST, Gaithersburg, MD) software with a similarity of >70% and finally verified by our in-house compound library (containing ∼ 1000 mammalian metabolites). Both mass-spectrum and retention times were used to achieve precise compound annotations.
Quantitative analysis of SCFAs
The extraction and derivatization procedures for SCFAs in caecal contents were 
Data analysis
For the microbiome data, quality control of the raw data was performed using BGI's standard bioinformatics analysis pipeline. The acquired clean data with paired-end 16S rDNA reads were merged together using FLASH 61 For the metabolome data, internal standards and any known artificial peaks, such as peaks caused by noise, column bleed, and the BSTFA derivatization procedure were removed from the data set. The resulting data were normalized to an internal standard prior to statistical analysis. The normalized data were mean centered and unit variance scaled during chemometric data analysis in the SIMCA-P+ software package (version 13.0, Umetrics, Umea, Sweden). Differential variables were selected with the criteria of variable importance in the projection (VIP > 1) in the PLS model and p < 0.05 in a two-tailed unpaired t-test. The corresponding fold change shows how these selected differential metabolites varied between groups. To explore the functional correlation between the changes on metabolome perturbations and gut microbiome, Spearman's correlation analyses were performed using SPSS v22 (IBM, USA).
Data availability
The data that support the findings of this study are available from the authors on reasonable request. The mouse gut 16S rRNA gene sequencing data was deposited under NCBI BioProject PRJNA492383 and sequence reads are available at NCBI under BioSample IDs SAMN10101900. 
